nodes	percent_of_prediction	percent_of_DWPC	metapath
Modafinil—CYP3A5—Docetaxel—head and neck cancer	0.131	0.269	CbGbCtD
Modafinil—CYP1A2—Fluorouracil—head and neck cancer	0.128	0.262	CbGbCtD
Modafinil—CYP2C9—Fluorouracil—head and neck cancer	0.115	0.236	CbGbCtD
Modafinil—CYP3A4—Vinblastine—head and neck cancer	0.0621	0.127	CbGbCtD
Modafinil—CYP3A4—Docetaxel—head and neck cancer	0.0512	0.105	CbGbCtD
Modafinil—Pain in jaw—Vinblastine—head and neck cancer	0.021	0.0507	CcSEcCtD
Modafinil—Hepatic enzyme increased—Hydroxyurea—head and neck cancer	0.00661	0.0159	CcSEcCtD
Modafinil—Myocardial ischaemia—Fluorouracil—head and neck cancer	0.0056	0.0135	CcSEcCtD
Modafinil—Herpes simplex—Fluorouracil—head and neck cancer	0.00489	0.0118	CcSEcCtD
Modafinil—Leukocytosis—Fluorouracil—head and neck cancer	0.00479	0.0115	CcSEcCtD
Modafinil—Dermatitis contact—Fluorouracil—head and neck cancer	0.00445	0.0107	CcSEcCtD
Modafinil—Pancytopenia—Vinblastine—head and neck cancer	0.00409	0.00985	CcSEcCtD
Modafinil—Myocardial ischaemia—Docetaxel—head and neck cancer	0.00404	0.00974	CcSEcCtD
Modafinil—Depression—Vinblastine—head and neck cancer	0.00383	0.00922	CcSEcCtD
Modafinil—Pancytopenia—Hydroxyurea—head and neck cancer	0.00373	0.00898	CcSEcCtD
Modafinil—Photosensitivity—Fluorouracil—head and neck cancer	0.00372	0.00897	CcSEcCtD
Modafinil—Agranulocytosis—Vinblastine—head and neck cancer	0.00358	0.00863	CcSEcCtD
Modafinil—Weight increased—Hydroxyurea—head and neck cancer	0.00357	0.00861	CcSEcCtD
Modafinil—Drowsiness—Hydroxyurea—head and neck cancer	0.0035	0.00843	CcSEcCtD
Modafinil—Amnesia—Fluorouracil—head and neck cancer	0.00348	0.00838	CcSEcCtD
Modafinil—Pharyngitis—Vinblastine—head and neck cancer	0.00342	0.00824	CcSEcCtD
Modafinil—Hearing impaired—Docetaxel—head and neck cancer	0.00341	0.00823	CcSEcCtD
Modafinil—Stomatitis—Hydroxyurea—head and neck cancer	0.00341	0.00822	CcSEcCtD
Modafinil—Osteoarthritis—Fluorouracil—head and neck cancer	0.00327	0.00787	CcSEcCtD
Modafinil—Blood pressure increased—Docetaxel—head and neck cancer	0.00325	0.00783	CcSEcCtD
Modafinil—Nepafenac—PTGS2—head and neck cancer	0.00319	0.201	CrCbGaD
Modafinil—Influenza like illness—Docetaxel—head and neck cancer	0.00316	0.0076	CcSEcCtD
Modafinil—Hallucination—Hydroxyurea—head and neck cancer	0.00313	0.00753	CcSEcCtD
Modafinil—Irritability—Fluorouracil—head and neck cancer	0.00312	0.00752	CcSEcCtD
Modafinil—Cardiac arrest—Fluorouracil—head and neck cancer	0.00311	0.00749	CcSEcCtD
Modafinil—Ataxia—Fluorouracil—head and neck cancer	0.00307	0.0074	CcSEcCtD
Modafinil—Dry skin—Fluorouracil—head and neck cancer	0.003	0.00722	CcSEcCtD
Modafinil—Muscular weakness—Fluorouracil—head and neck cancer	0.00288	0.00695	CcSEcCtD
Modafinil—Angiopathy—Hydroxyurea—head and neck cancer	0.00285	0.00687	CcSEcCtD
Modafinil—Chills—Hydroxyurea—head and neck cancer	0.00282	0.00679	CcSEcCtD
Modafinil—Eosinophilia—Fluorouracil—head and neck cancer	0.0028	0.00674	CcSEcCtD
Modafinil—Ill-defined disorder—Vinblastine—head and neck cancer	0.00278	0.0067	CcSEcCtD
Modafinil—Anaemia—Vinblastine—head and neck cancer	0.00277	0.00668	CcSEcCtD
Modafinil—Malaise—Vinblastine—head and neck cancer	0.0027	0.00651	CcSEcCtD
Modafinil—Vertigo—Vinblastine—head and neck cancer	0.00269	0.00649	CcSEcCtD
Modafinil—Pancytopenia—Fluorouracil—head and neck cancer	0.00268	0.00646	CcSEcCtD
Modafinil—Warfarin—CYP1A1—head and neck cancer	0.00268	0.169	CrCbGaD
Modafinil—Oxaprozin—PTGS2—head and neck cancer	0.00265	0.167	CrCbGaD
Modafinil—Convulsion—Vinblastine—head and neck cancer	0.0026	0.00626	CcSEcCtD
Modafinil—Hypertension—Vinblastine—head and neck cancer	0.00259	0.00624	CcSEcCtD
Modafinil—Photosensitivity reaction—Fluorouracil—head and neck cancer	0.00258	0.00621	CcSEcCtD
Modafinil—Ill-defined disorder—Hydroxyurea—head and neck cancer	0.00254	0.00611	CcSEcCtD
Modafinil—Pneumonia—Fluorouracil—head and neck cancer	0.00253	0.0061	CcSEcCtD
Modafinil—Anaemia—Hydroxyurea—head and neck cancer	0.00253	0.00609	CcSEcCtD
Modafinil—Discomfort—Vinblastine—head and neck cancer	0.00252	0.00608	CcSEcCtD
Modafinil—Malaise—Hydroxyurea—head and neck cancer	0.00247	0.00594	CcSEcCtD
Modafinil—Stomatitis—Fluorouracil—head and neck cancer	0.00245	0.00592	CcSEcCtD
Modafinil—Conjunctivitis—Fluorouracil—head and neck cancer	0.00245	0.0059	CcSEcCtD
Modafinil—Urinary tract infection—Fluorouracil—head and neck cancer	0.00245	0.0059	CcSEcCtD
Modafinil—Epistaxis—Fluorouracil—head and neck cancer	0.00238	0.00572	CcSEcCtD
Modafinil—Convulsion—Hydroxyurea—head and neck cancer	0.00237	0.00571	CcSEcCtD
Modafinil—Sinusitis—Fluorouracil—head and neck cancer	0.00236	0.00569	CcSEcCtD
Modafinil—Agranulocytosis—Fluorouracil—head and neck cancer	0.00235	0.00566	CcSEcCtD
Modafinil—Anorexia—Vinblastine—head and neck cancer	0.00233	0.00562	CcSEcCtD
Modafinil—Migraine—Docetaxel—head and neck cancer	0.00232	0.00559	CcSEcCtD
Modafinil—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—head and neck cancer	0.00231	0.00557	CcSEcCtD
Modafinil—Discomfort—Hydroxyurea—head and neck cancer	0.0023	0.00554	CcSEcCtD
Modafinil—Rhinitis—Fluorouracil—head and neck cancer	0.00227	0.00546	CcSEcCtD
Modafinil—Pharyngitis—Fluorouracil—head and neck cancer	0.00224	0.00541	CcSEcCtD
Modafinil—Oedema—Hydroxyurea—head and neck cancer	0.00223	0.00538	CcSEcCtD
Modafinil—Ataxia—Docetaxel—head and neck cancer	0.00222	0.00534	CcSEcCtD
Modafinil—Infection—Hydroxyurea—head and neck cancer	0.00222	0.00534	CcSEcCtD
Modafinil—Paraesthesia—Vinblastine—head and neck cancer	0.0022	0.00529	CcSEcCtD
Modafinil—Fenoprofen—PTGS2—head and neck cancer	0.00219	0.138	CrCbGaD
Modafinil—Nervous system disorder—Hydroxyurea—head and neck cancer	0.00219	0.00527	CcSEcCtD
Modafinil—Skin disorder—Hydroxyurea—head and neck cancer	0.00217	0.00522	CcSEcCtD
Modafinil—Dry skin—Docetaxel—head and neck cancer	0.00216	0.00521	CcSEcCtD
Modafinil—Abdominal pain upper—Docetaxel—head and neck cancer	0.00215	0.00519	CcSEcCtD
Modafinil—Anorexia—Hydroxyurea—head and neck cancer	0.00213	0.00513	CcSEcCtD
Modafinil—Decreased appetite—Vinblastine—head and neck cancer	0.00213	0.00513	CcSEcCtD
Modafinil—Aspartate aminotransferase increased—Docetaxel—head and neck cancer	0.00212	0.00512	CcSEcCtD
Modafinil—Toxic epidermal necrolysis—Docetaxel—head and neck cancer	0.00212	0.00512	CcSEcCtD
Modafinil—Cinnarizine—CYP1A1—head and neck cancer	0.00212	0.134	CrCbGaD
Modafinil—Constipation—Vinblastine—head and neck cancer	0.00209	0.00504	CcSEcCtD
Modafinil—Pain—Vinblastine—head and neck cancer	0.00209	0.00504	CcSEcCtD
Modafinil—Arrhythmia—Fluorouracil—head and neck cancer	0.00202	0.00487	CcSEcCtD
Modafinil—Feeling abnormal—Vinblastine—head and neck cancer	0.00202	0.00486	CcSEcCtD
Modafinil—Gastrointestinal pain—Vinblastine—head and neck cancer	0.002	0.00482	CcSEcCtD
Modafinil—Dyspnoea—Hydroxyurea—head and neck cancer	0.00199	0.00479	CcSEcCtD
Modafinil—Somnolence—Hydroxyurea—head and neck cancer	0.00198	0.00478	CcSEcCtD
Modafinil—Dyspepsia—Hydroxyurea—head and neck cancer	0.00196	0.00473	CcSEcCtD
Modafinil—Decreased appetite—Hydroxyurea—head and neck cancer	0.00194	0.00467	CcSEcCtD
Modafinil—Pancytopenia—Docetaxel—head and neck cancer	0.00194	0.00467	CcSEcCtD
Modafinil—Abdominal pain—Vinblastine—head and neck cancer	0.00193	0.00466	CcSEcCtD
Modafinil—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	0.00193	0.00464	CcSEcCtD
Modafinil—Fatigue—Hydroxyurea—head and neck cancer	0.00192	0.00464	CcSEcCtD
Modafinil—Pain—Hydroxyurea—head and neck cancer	0.00191	0.0046	CcSEcCtD
Modafinil—Constipation—Hydroxyurea—head and neck cancer	0.00191	0.0046	CcSEcCtD
Modafinil—Weight increased—Docetaxel—head and neck cancer	0.00186	0.00447	CcSEcCtD
Modafinil—Weight decreased—Docetaxel—head and neck cancer	0.00184	0.00444	CcSEcCtD
Modafinil—Feeling abnormal—Hydroxyurea—head and neck cancer	0.00184	0.00443	CcSEcCtD
Modafinil—Pneumonia—Docetaxel—head and neck cancer	0.00183	0.00441	CcSEcCtD
Modafinil—Anaemia—Fluorouracil—head and neck cancer	0.00182	0.00438	CcSEcCtD
Modafinil—Hypersensitivity—Vinblastine—head and neck cancer	0.0018	0.00434	CcSEcCtD
Modafinil—Stevens-Johnson syndrome—Docetaxel—head and neck cancer	0.0018	0.00434	CcSEcCtD
Modafinil—Stomatitis—Docetaxel—head and neck cancer	0.00177	0.00427	CcSEcCtD
Modafinil—Conjunctivitis—Docetaxel—head and neck cancer	0.00177	0.00426	CcSEcCtD
Modafinil—Body temperature increased—Hydroxyurea—head and neck cancer	0.00176	0.00425	CcSEcCtD
Modafinil—Asthenia—Vinblastine—head and neck cancer	0.00176	0.00423	CcSEcCtD
Modafinil—Phenylbutazone—PTGS2—head and neck cancer	0.00175	0.11	CrCbGaD
Modafinil—Epistaxis—Docetaxel—head and neck cancer	0.00171	0.00413	CcSEcCtD
Modafinil—Convulsion—Fluorouracil—head and neck cancer	0.00171	0.00411	CcSEcCtD
Modafinil—Agranulocytosis—Docetaxel—head and neck cancer	0.0017	0.00409	CcSEcCtD
Modafinil—Chest pain—Fluorouracil—head and neck cancer	0.00168	0.00404	CcSEcCtD
Modafinil—Myalgia—Fluorouracil—head and neck cancer	0.00168	0.00404	CcSEcCtD
Modafinil—Diarrhoea—Vinblastine—head and neck cancer	0.00167	0.00403	CcSEcCtD
Modafinil—Discomfort—Fluorouracil—head and neck cancer	0.00166	0.00399	CcSEcCtD
Modafinil—Hypersensitivity—Hydroxyurea—head and neck cancer	0.00164	0.00396	CcSEcCtD
Modafinil—Rhinitis—Docetaxel—head and neck cancer	0.00164	0.00394	CcSEcCtD
Modafinil—Confusional state—Fluorouracil—head and neck cancer	0.00162	0.0039	CcSEcCtD
Modafinil—Pharyngitis—Docetaxel—head and neck cancer	0.00162	0.0039	CcSEcCtD
Modafinil—Dizziness—Vinblastine—head and neck cancer	0.00162	0.0039	CcSEcCtD
Modafinil—Urinary tract disorder—Docetaxel—head and neck cancer	0.00161	0.00388	CcSEcCtD
Modafinil—Oedema peripheral—Docetaxel—head and neck cancer	0.00161	0.00387	CcSEcCtD
Modafinil—Anaphylactic shock—Fluorouracil—head and neck cancer	0.00161	0.00387	CcSEcCtD
Modafinil—Oedema—Fluorouracil—head and neck cancer	0.00161	0.00387	CcSEcCtD
Modafinil—Connective tissue disorder—Docetaxel—head and neck cancer	0.0016	0.00386	CcSEcCtD
Modafinil—Asthenia—Hydroxyurea—head and neck cancer	0.0016	0.00386	CcSEcCtD
Modafinil—Urethral disorder—Docetaxel—head and neck cancer	0.0016	0.00385	CcSEcCtD
Modafinil—Infection—Fluorouracil—head and neck cancer	0.0016	0.00385	CcSEcCtD
Modafinil—Nervous system disorder—Fluorouracil—head and neck cancer	0.00158	0.0038	CcSEcCtD
Modafinil—Visual impairment—Docetaxel—head and neck cancer	0.00157	0.00379	CcSEcCtD
Modafinil—Tachycardia—Fluorouracil—head and neck cancer	0.00157	0.00378	CcSEcCtD
Modafinil—Vomiting—Vinblastine—head and neck cancer	0.00156	0.00375	CcSEcCtD
Modafinil—Erythema multiforme—Docetaxel—head and neck cancer	0.00154	0.00372	CcSEcCtD
Modafinil—Headache—Vinblastine—head and neck cancer	0.00153	0.00369	CcSEcCtD
Modafinil—Anorexia—Fluorouracil—head and neck cancer	0.00153	0.00369	CcSEcCtD
Modafinil—Diarrhoea—Hydroxyurea—head and neck cancer	0.00153	0.00368	CcSEcCtD
Modafinil—Cardiac disorder—Docetaxel—head and neck cancer	0.00151	0.00365	CcSEcCtD
Modafinil—Hypotension—Fluorouracil—head and neck cancer	0.0015	0.00362	CcSEcCtD
Modafinil—Angiopathy—Docetaxel—head and neck cancer	0.00148	0.00357	CcSEcCtD
Modafinil—Dizziness—Hydroxyurea—head and neck cancer	0.00148	0.00356	CcSEcCtD
Modafinil—Immune system disorder—Docetaxel—head and neck cancer	0.00147	0.00355	CcSEcCtD
Modafinil—Mediastinal disorder—Docetaxel—head and neck cancer	0.00147	0.00354	CcSEcCtD
Modafinil—Chills—Docetaxel—head and neck cancer	0.00146	0.00353	CcSEcCtD
Modafinil—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	0.00146	0.00353	CcSEcCtD
Modafinil—Arrhythmia—Docetaxel—head and neck cancer	0.00146	0.00351	CcSEcCtD
Modafinil—Nausea—Vinblastine—head and neck cancer	0.00145	0.0035	CcSEcCtD
Modafinil—Insomnia—Fluorouracil—head and neck cancer	0.00145	0.0035	CcSEcCtD
Modafinil—Paraesthesia—Fluorouracil—head and neck cancer	0.00144	0.00348	CcSEcCtD
Modafinil—Dyspnoea—Fluorouracil—head and neck cancer	0.00143	0.00345	CcSEcCtD
Modafinil—Mental disorder—Docetaxel—head and neck cancer	0.00143	0.00344	CcSEcCtD
Modafinil—Somnolence—Fluorouracil—head and neck cancer	0.00143	0.00344	CcSEcCtD
Modafinil—Malnutrition—Docetaxel—head and neck cancer	0.00142	0.00342	CcSEcCtD
Modafinil—Vomiting—Hydroxyurea—head and neck cancer	0.00142	0.00342	CcSEcCtD
Modafinil—Dyspepsia—Fluorouracil—head and neck cancer	0.00141	0.00341	CcSEcCtD
Modafinil—Rash—Hydroxyurea—head and neck cancer	0.00141	0.00339	CcSEcCtD
Modafinil—Dermatitis—Hydroxyurea—head and neck cancer	0.00141	0.00339	CcSEcCtD
Modafinil—Headache—Hydroxyurea—head and neck cancer	0.0014	0.00337	CcSEcCtD
Modafinil—Decreased appetite—Fluorouracil—head and neck cancer	0.0014	0.00336	CcSEcCtD
Modafinil—Dysgeusia—Docetaxel—head and neck cancer	0.00139	0.00335	CcSEcCtD
Modafinil—Gastrointestinal disorder—Fluorouracil—head and neck cancer	0.00139	0.00334	CcSEcCtD
Modafinil—Back pain—Docetaxel—head and neck cancer	0.00137	0.00331	CcSEcCtD
Modafinil—Pain—Fluorouracil—head and neck cancer	0.00137	0.00331	CcSEcCtD
Modafinil—Muscle spasms—Docetaxel—head and neck cancer	0.00137	0.00329	CcSEcCtD
Modafinil—Nausea—Hydroxyurea—head and neck cancer	0.00133	0.00319	CcSEcCtD
Modafinil—Feeling abnormal—Fluorouracil—head and neck cancer	0.00132	0.00319	CcSEcCtD
Modafinil—Anaemia—Docetaxel—head and neck cancer	0.00131	0.00316	CcSEcCtD
Modafinil—CYP3A5—Xenobiotics—CYP1A1—head and neck cancer	0.0013	0.016	CbGpPWpGaD
Modafinil—Ketoprofen—PTGS2—head and neck cancer	0.00129	0.0814	CrCbGaD
Modafinil—Urticaria—Fluorouracil—head and neck cancer	0.00128	0.00307	CcSEcCtD
Modafinil—Syncope—Docetaxel—head and neck cancer	0.00127	0.00307	CcSEcCtD
Modafinil—Body temperature increased—Fluorouracil—head and neck cancer	0.00127	0.00306	CcSEcCtD
Modafinil—Palpitations—Docetaxel—head and neck cancer	0.00126	0.00302	CcSEcCtD
Modafinil—CYP3A5—Tamoxifen metabolism—CYP1A1—head and neck cancer	0.00125	0.0154	CbGpPWpGaD
Modafinil—Loss of consciousness—Docetaxel—head and neck cancer	0.00125	0.00301	CcSEcCtD
Modafinil—Cough—Docetaxel—head and neck cancer	0.00124	0.00299	CcSEcCtD
Modafinil—Convulsion—Docetaxel—head and neck cancer	0.00123	0.00297	CcSEcCtD
Modafinil—Hypertension—Docetaxel—head and neck cancer	0.00123	0.00296	CcSEcCtD
Modafinil—Myalgia—Docetaxel—head and neck cancer	0.00121	0.00291	CcSEcCtD
Modafinil—Chest pain—Docetaxel—head and neck cancer	0.00121	0.00291	CcSEcCtD
Modafinil—Arthralgia—Docetaxel—head and neck cancer	0.00121	0.00291	CcSEcCtD
Modafinil—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—head and neck cancer	0.0012	0.00289	CcSEcCtD
Modafinil—Hypersensitivity—Fluorouracil—head and neck cancer	0.00118	0.00285	CcSEcCtD
Modafinil—Dry mouth—Docetaxel—head and neck cancer	0.00118	0.00285	CcSEcCtD
Modafinil—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—head and neck cancer	0.00117	0.0145	CbGpPWpGaD
Modafinil—Confusional state—Docetaxel—head and neck cancer	0.00117	0.00282	CcSEcCtD
Modafinil—Oedema—Docetaxel—head and neck cancer	0.00116	0.00279	CcSEcCtD
Modafinil—Anaphylactic shock—Docetaxel—head and neck cancer	0.00116	0.00279	CcSEcCtD
Modafinil—Infection—Docetaxel—head and neck cancer	0.00115	0.00278	CcSEcCtD
Modafinil—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—head and neck cancer	0.00114	0.0141	CbGpPWpGaD
Modafinil—Shock—Docetaxel—head and neck cancer	0.00114	0.00275	CcSEcCtD
Modafinil—Nervous system disorder—Docetaxel—head and neck cancer	0.00114	0.00274	CcSEcCtD
Modafinil—Pruritus—Fluorouracil—head and neck cancer	0.00114	0.00274	CcSEcCtD
Modafinil—Tachycardia—Docetaxel—head and neck cancer	0.00113	0.00273	CcSEcCtD
Modafinil—Skin disorder—Docetaxel—head and neck cancer	0.00113	0.00271	CcSEcCtD
Modafinil—Anorexia—Docetaxel—head and neck cancer	0.00111	0.00266	CcSEcCtD
Modafinil—CYP1A2—Estrogen Receptor Pathway—CYP1A1—head and neck cancer	0.0011	0.0136	CbGpPWpGaD
Modafinil—Diarrhoea—Fluorouracil—head and neck cancer	0.0011	0.00265	CcSEcCtD
Modafinil—Hypotension—Docetaxel—head and neck cancer	0.00108	0.00261	CcSEcCtD
Modafinil—Dizziness—Fluorouracil—head and neck cancer	0.00106	0.00256	CcSEcCtD
Modafinil—Musculoskeletal discomfort—Docetaxel—head and neck cancer	0.00106	0.00255	CcSEcCtD
Modafinil—Insomnia—Docetaxel—head and neck cancer	0.00105	0.00253	CcSEcCtD
Modafinil—Paraesthesia—Docetaxel—head and neck cancer	0.00104	0.00251	CcSEcCtD
Modafinil—Dyspnoea—Docetaxel—head and neck cancer	0.00103	0.00249	CcSEcCtD
Modafinil—Somnolence—Docetaxel—head and neck cancer	0.00103	0.00248	CcSEcCtD
Modafinil—Vomiting—Fluorouracil—head and neck cancer	0.00102	0.00246	CcSEcCtD
Modafinil—Dyspepsia—Docetaxel—head and neck cancer	0.00102	0.00246	CcSEcCtD
Modafinil—Rash—Fluorouracil—head and neck cancer	0.00101	0.00244	CcSEcCtD
Modafinil—Dermatitis—Fluorouracil—head and neck cancer	0.00101	0.00244	CcSEcCtD
Modafinil—Decreased appetite—Docetaxel—head and neck cancer	0.00101	0.00243	CcSEcCtD
Modafinil—Headache—Fluorouracil—head and neck cancer	0.00101	0.00242	CcSEcCtD
Modafinil—CYP2C19—Xenobiotics—CYP1A1—head and neck cancer	0.001	0.0124	CbGpPWpGaD
Modafinil—Gastrointestinal disorder—Docetaxel—head and neck cancer	0.001	0.00241	CcSEcCtD
Modafinil—Fatigue—Docetaxel—head and neck cancer	0.001	0.00241	CcSEcCtD
Modafinil—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—head and neck cancer	0.000999	0.0124	CbGpPWpGaD
Modafinil—Pain—Docetaxel—head and neck cancer	0.000991	0.00239	CcSEcCtD
Modafinil—Constipation—Docetaxel—head and neck cancer	0.000991	0.00239	CcSEcCtD
Modafinil—CYP2C19—Tamoxifen metabolism—CYP1A1—head and neck cancer	0.000965	0.0119	CbGpPWpGaD
Modafinil—Feeling abnormal—Docetaxel—head and neck cancer	0.000955	0.0023	CcSEcCtD
Modafinil—Nausea—Fluorouracil—head and neck cancer	0.000954	0.0023	CcSEcCtD
Modafinil—Gastrointestinal pain—Docetaxel—head and neck cancer	0.000948	0.00228	CcSEcCtD
Modafinil—CYP1A2—Fatty Acid Omega Oxidation—CYP1A1—head and neck cancer	0.000935	0.0116	CbGpPWpGaD
Modafinil—Abdominal pain—Docetaxel—head and neck cancer	0.000916	0.00221	CcSEcCtD
Modafinil—Body temperature increased—Docetaxel—head and neck cancer	0.000916	0.00221	CcSEcCtD
Modafinil—CYP2C9—Xenobiotics—CYP1A1—head and neck cancer	0.000915	0.0113	CbGpPWpGaD
Modafinil—CYP1A2—Estrogen metabolism—GSTM1—head and neck cancer	0.000898	0.0111	CbGpPWpGaD
Modafinil—CYP2C9—Tamoxifen metabolism—CYP1A1—head and neck cancer	0.00088	0.0109	CbGpPWpGaD
Modafinil—Hypersensitivity—Docetaxel—head and neck cancer	0.000854	0.00206	CcSEcCtD
Modafinil—CYP1A2—Estrogen metabolism—CYP1A1—head and neck cancer	0.000851	0.0105	CbGpPWpGaD
Modafinil—Asthenia—Docetaxel—head and neck cancer	0.000832	0.002	CcSEcCtD
Modafinil—Pruritus—Docetaxel—head and neck cancer	0.00082	0.00198	CcSEcCtD
Modafinil—Diarrhoea—Docetaxel—head and neck cancer	0.000793	0.00191	CcSEcCtD
Modafinil—CYP1A2—Xenobiotics—CYP1A1—head and neck cancer	0.000782	0.00967	CbGpPWpGaD
Modafinil—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—head and neck cancer	0.000771	0.00953	CbGpPWpGaD
Modafinil—Dizziness—Docetaxel—head and neck cancer	0.000767	0.00185	CcSEcCtD
Modafinil—CYP1A2—Tamoxifen metabolism—CYP1A1—head and neck cancer	0.000752	0.0093	CbGpPWpGaD
Modafinil—CYP2C19—Melatonin metabolism and effects—CYP1A1—head and neck cancer	0.000746	0.00922	CbGpPWpGaD
Modafinil—Vomiting—Docetaxel—head and neck cancer	0.000737	0.00178	CcSEcCtD
Modafinil—Rash—Docetaxel—head and neck cancer	0.000731	0.00176	CcSEcCtD
Modafinil—Dermatitis—Docetaxel—head and neck cancer	0.00073	0.00176	CcSEcCtD
Modafinil—SLC6A3—NRF2 pathway—TGFA—head and neck cancer	0.00073	0.00902	CbGpPWpGaD
Modafinil—Headache—Docetaxel—head and neck cancer	0.000726	0.00175	CcSEcCtD
Modafinil—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—head and neck cancer	0.000722	0.00892	CbGpPWpGaD
Modafinil—ADRA1B—G alpha (q) signalling events—KISS1—head and neck cancer	0.000721	0.00891	CbGpPWpGaD
Modafinil—CYP3A4—Estrogen metabolism—GSTM1—head and neck cancer	0.000693	0.00856	CbGpPWpGaD
Modafinil—Nausea—Docetaxel—head and neck cancer	0.000689	0.00166	CcSEcCtD
Modafinil—SLC6A3—Dopaminergic Neurogenesis—STAT3—head and neck cancer	0.000661	0.00817	CbGpPWpGaD
Modafinil—CYP3A4—Estrogen metabolism—CYP1A1—head and neck cancer	0.000657	0.00812	CbGpPWpGaD
Modafinil—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—KISS1—head and neck cancer	0.000645	0.00797	CbGpPWpGaD
Modafinil—CYP3A4—Xenobiotics—CYP1A1—head and neck cancer	0.000604	0.00746	CbGpPWpGaD
Modafinil—ADRA1B—G alpha (q) signalling events—GRP—head and neck cancer	0.000594	0.00734	CbGpPWpGaD
Modafinil—CYP1A2—Melatonin metabolism and effects—CYP1A1—head and neck cancer	0.000581	0.00718	CbGpPWpGaD
Modafinil—CYP3A4—Tamoxifen metabolism—CYP1A1—head and neck cancer	0.000581	0.00718	CbGpPWpGaD
Modafinil—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000552	0.00682	CbGpPWpGaD
Modafinil—CYP2B6—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000544	0.00673	CbGpPWpGaD
Modafinil—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000539	0.00666	CbGpPWpGaD
Modafinil—CYP3A5—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000532	0.00658	CbGpPWpGaD
Modafinil—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—GRP—head and neck cancer	0.000531	0.00657	CbGpPWpGaD
Modafinil—CYP1A2—Estrogen Receptor Pathway—STAT3—head and neck cancer	0.000512	0.00633	CbGpPWpGaD
Modafinil—CYP1A2—Phase II conjugation—NAT2—head and neck cancer	0.000511	0.00631	CbGpPWpGaD
Modafinil—CYP2B6—Biological oxidations—NAT2—head and neck cancer	0.000507	0.00627	CbGpPWpGaD
Modafinil—CYP2B6—Metapathway biotransformation—NAT2—head and neck cancer	0.0005	0.00618	CbGpPWpGaD
Modafinil—CYP3A5—Biological oxidations—NAT2—head and neck cancer	0.000496	0.00613	CbGpPWpGaD
Modafinil—CYP3A5—Metapathway biotransformation—NAT2—head and neck cancer	0.000489	0.00604	CbGpPWpGaD
Modafinil—CYP2C19—Arachidonic acid metabolism—GPX1—head and neck cancer	0.000487	0.00602	CbGpPWpGaD
Modafinil—CYP2C19—Arachidonic acid metabolism—CYP1A1—head and neck cancer	0.000482	0.00596	CbGpPWpGaD
Modafinil—ADRA1B—Class A/1 (Rhodopsin-like receptors)—KISS1—head and neck cancer	0.000478	0.0059	CbGpPWpGaD
Modafinil—CYP2B6—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000447	0.00553	CbGpPWpGaD
Modafinil—CYP2C9—Arachidonic acid metabolism—GPX1—head and neck cancer	0.000444	0.00549	CbGpPWpGaD
Modafinil—CYP2C9—Arachidonic acid metabolism—CYP1A1—head and neck cancer	0.00044	0.00544	CbGpPWpGaD
Modafinil—CYP3A5—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000437	0.0054	CbGpPWpGaD
Modafinil—SLC6A3—NRF2 pathway—GSTM1—head and neck cancer	0.000424	0.00524	CbGpPWpGaD
Modafinil—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000417	0.00515	CbGpPWpGaD
Modafinil—CYP2C19—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000411	0.00508	CbGpPWpGaD
Modafinil—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1A1—head and neck cancer	0.000402	0.00497	CbGpPWpGaD
Modafinil—CYP1A2—Aryl Hydrocarbon Receptor—CYP1A1—head and neck cancer	0.000402	0.00497	CbGpPWpGaD
Modafinil—CYP1A2—Tryptophan metabolism—CYP1A1—head and neck cancer	0.000402	0.00497	CbGpPWpGaD
Modafinil—ADRA1B—Class A/1 (Rhodopsin-like receptors)—GRP—head and neck cancer	0.000393	0.00486	CbGpPWpGaD
Modafinil—CYP2C19—Biological oxidations—NAT2—head and neck cancer	0.000383	0.00474	CbGpPWpGaD
Modafinil—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.00038	0.0047	CbGpPWpGaD
Modafinil—CYP1A2—Arachidonic acid metabolism—GPX1—head and neck cancer	0.00038	0.00469	CbGpPWpGaD
Modafinil—CYP2C19—Metapathway biotransformation—NAT2—head and neck cancer	0.000378	0.00467	CbGpPWpGaD
Modafinil—CYP1A2—Arachidonic acid metabolism—CYP1A1—head and neck cancer	0.000376	0.00464	CbGpPWpGaD
Modafinil—CYP2C9—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000375	0.00464	CbGpPWpGaD
Modafinil—ADRA1B—GPCR ligand binding—KISS1—head and neck cancer	0.000364	0.0045	CbGpPWpGaD
Modafinil—CYP2C9—Biological oxidations—NAT2—head and neck cancer	0.00035	0.00432	CbGpPWpGaD
Modafinil—SLC6A3—Transmembrane transport of small molecules—ATP7B—head and neck cancer	0.000348	0.0043	CbGpPWpGaD
Modafinil—CYP2C9—Metapathway biotransformation—NAT2—head and neck cancer	0.000345	0.00426	CbGpPWpGaD
Modafinil—CYP2C19—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000338	0.00418	CbGpPWpGaD
Modafinil—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000325	0.00401	CbGpPWpGaD
Modafinil—CYP1A2—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000321	0.00396	CbGpPWpGaD
Modafinil—CYP3A4—Tryptophan metabolism—CYP1A1—head and neck cancer	0.00031	0.00383	CbGpPWpGaD
Modafinil—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000308	0.00381	CbGpPWpGaD
Modafinil—ADRA1B—GPCR ligand binding—GRP—head and neck cancer	0.0003	0.0037	CbGpPWpGaD
Modafinil—CYP1A2—Biological oxidations—NAT2—head and neck cancer	0.000299	0.00369	CbGpPWpGaD
Modafinil—CYP1A2—Metapathway biotransformation—NAT2—head and neck cancer	0.000295	0.00364	CbGpPWpGaD
Modafinil—CYP2C19—Arachidonic acid metabolism—PTGS2—head and neck cancer	0.000287	0.00355	CbGpPWpGaD
Modafinil—ADRA1B—LPA receptor mediated events—EGFR—head and neck cancer	0.000285	0.00353	CbGpPWpGaD
Modafinil—CYP1A2—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000263	0.00325	CbGpPWpGaD
Modafinil—CYP2C9—Arachidonic acid metabolism—PTGS2—head and neck cancer	0.000262	0.00323	CbGpPWpGaD
Modafinil—CYP1A2—Phase II conjugation—GSTM1—head and neck cancer	0.000252	0.00312	CbGpPWpGaD
Modafinil—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000251	0.0031	CbGpPWpGaD
Modafinil—CYP2B6—Biological oxidations—GSTM1—head and neck cancer	0.000251	0.0031	CbGpPWpGaD
Modafinil—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000247	0.00306	CbGpPWpGaD
Modafinil—CYP2B6—Metapathway biotransformation—GSTM1—head and neck cancer	0.000247	0.00305	CbGpPWpGaD
Modafinil—CYP3A5—Biological oxidations—GSTM1—head and neck cancer	0.000245	0.00303	CbGpPWpGaD
Modafinil—CYP3A5—Metapathway biotransformation—GSTM1—head and neck cancer	0.000242	0.00299	CbGpPWpGaD
Modafinil—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—head and neck cancer	0.000239	0.00295	CbGpPWpGaD
Modafinil—CYP2B6—Biological oxidations—CYP1A1—head and neck cancer	0.000238	0.00294	CbGpPWpGaD
Modafinil—CYP2B6—Metapathway biotransformation—CYP1A1—head and neck cancer	0.000234	0.0029	CbGpPWpGaD
Modafinil—ADRA1B—AMPK Signaling—PIK3CA—head and neck cancer	0.000233	0.00288	CbGpPWpGaD
Modafinil—CYP3A5—Biological oxidations—CYP1A1—head and neck cancer	0.000232	0.00287	CbGpPWpGaD
Modafinil—CYP3A4—Biological oxidations—NAT2—head and neck cancer	0.000231	0.00285	CbGpPWpGaD
Modafinil—ADRA1B—LPA receptor mediated events—HRAS—head and neck cancer	0.000229	0.00283	CbGpPWpGaD
Modafinil—CYP3A5—Metapathway biotransformation—CYP1A1—head and neck cancer	0.000229	0.00283	CbGpPWpGaD
Modafinil—CYP3A4—Metapathway biotransformation—NAT2—head and neck cancer	0.000227	0.00281	CbGpPWpGaD
Modafinil—ADRA1B—AMPK Signaling—TP53—head and neck cancer	0.000226	0.00279	CbGpPWpGaD
Modafinil—CYP1A2—Arachidonic acid metabolism—PTGS2—head and neck cancer	0.000223	0.00276	CbGpPWpGaD
Modafinil—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—head and neck cancer	0.000221	0.00274	CbGpPWpGaD
Modafinil—ADRA1B—G alpha (12/13) signalling events—PIK3CA—head and neck cancer	0.000218	0.0027	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—UROD—head and neck cancer	0.000209	0.00258	CbGpPWpGaD
Modafinil—ADRA1B—GPCR downstream signaling—KISS1—head and neck cancer	0.000206	0.00254	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—UROD—head and neck cancer	0.000204	0.00252	CbGpPWpGaD
Modafinil—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000203	0.00251	CbGpPWpGaD
Modafinil—ADRA1B—LPA receptor mediated events—AKT1—head and neck cancer	0.000202	0.0025	CbGpPWpGaD
Modafinil—ADRA1B—AMPK Signaling—AKT1—head and neck cancer	0.000191	0.00236	CbGpPWpGaD
Modafinil—CYP2C19—Biological oxidations—GSTM1—head and neck cancer	0.000189	0.00234	CbGpPWpGaD
Modafinil—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—head and neck cancer	0.000188	0.00233	CbGpPWpGaD
Modafinil—CYP2C19—Metapathway biotransformation—GSTM1—head and neck cancer	0.000187	0.00231	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—KISS1—head and neck cancer	0.000187	0.00231	CbGpPWpGaD
Modafinil—CYP2C19—Biological oxidations—CYP1A1—head and neck cancer	0.00018	0.00222	CbGpPWpGaD
Modafinil—CYP2C19—Metapathway biotransformation—CYP1A1—head and neck cancer	0.000177	0.00219	CbGpPWpGaD
Modafinil—CYP2C9—Biological oxidations—GSTM1—head and neck cancer	0.000173	0.00213	CbGpPWpGaD
Modafinil—CYP2C9—Metapathway biotransformation—GSTM1—head and neck cancer	0.00017	0.0021	CbGpPWpGaD
Modafinil—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—head and neck cancer	0.000169	0.00209	CbGpPWpGaD
Modafinil—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—head and neck cancer	0.000169	0.00209	CbGpPWpGaD
Modafinil—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—head and neck cancer	0.000169	0.00209	CbGpPWpGaD
Modafinil—ADRA1B—GPCR downstream signaling—GRP—head and neck cancer	0.000169	0.00209	CbGpPWpGaD
Modafinil—CYP2C9—Biological oxidations—CYP1A1—head and neck cancer	0.000164	0.00202	CbGpPWpGaD
Modafinil—CYP2C9—Metapathway biotransformation—CYP1A1—head and neck cancer	0.000161	0.002	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—UROD—head and neck cancer	0.000158	0.00195	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—GRP—head and neck cancer	0.000154	0.0019	CbGpPWpGaD
Modafinil—CYP1A2—Biological oxidations—GSTM1—head and neck cancer	0.000148	0.00182	CbGpPWpGaD
Modafinil—CYP1A2—Metapathway biotransformation—GSTM1—head and neck cancer	0.000146	0.0018	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—UROD—head and neck cancer	0.000144	0.00178	CbGpPWpGaD
Modafinil—CYP1A2—Biological oxidations—CYP1A1—head and neck cancer	0.00014	0.00173	CbGpPWpGaD
Modafinil—CYP1A2—Metapathway biotransformation—CYP1A1—head and neck cancer	0.000138	0.0017	CbGpPWpGaD
Modafinil—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—head and neck cancer	0.000136	0.00168	CbGpPWpGaD
Modafinil—SLC6A3—Transmission across Chemical Synapses—MAPK1—head and neck cancer	0.000132	0.00163	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—UROD—head and neck cancer	0.000123	0.00152	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	0.000123	0.00151	CbGpPWpGaD
Modafinil—CYP3A4—Biological oxidations—GSTM1—head and neck cancer	0.000114	0.00141	CbGpPWpGaD
Modafinil—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—head and neck cancer	0.000114	0.00141	CbGpPWpGaD
Modafinil—CYP3A4—Metapathway biotransformation—GSTM1—head and neck cancer	0.000112	0.00139	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	0.000112	0.00138	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—KISS1—head and neck cancer	0.00011	0.00136	CbGpPWpGaD
Modafinil—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—head and neck cancer	0.000108	0.00134	CbGpPWpGaD
Modafinil—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—head and neck cancer	0.000108	0.00134	CbGpPWpGaD
Modafinil—CYP3A4—Biological oxidations—CYP1A1—head and neck cancer	0.000108	0.00133	CbGpPWpGaD
Modafinil—CYP3A4—Metapathway biotransformation—CYP1A1—head and neck cancer	0.000106	0.00132	CbGpPWpGaD
Modafinil—SLC6A3—Transmission across Chemical Synapses—HRAS—head and neck cancer	0.000106	0.00131	CbGpPWpGaD
Modafinil—ADRA1B—G alpha (q) signalling events—PIK3CA—head and neck cancer	0.000105	0.0013	CbGpPWpGaD
Modafinil—SLC6A3—Neuronal System—MAPK1—head and neck cancer	0.000101	0.00125	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	9.54e-05	0.00118	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—UROD—head and neck cancer	9.49e-05	0.00117	CbGpPWpGaD
Modafinil—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—head and neck cancer	9.4e-05	0.00116	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—GRP—head and neck cancer	9.08e-05	0.00112	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—STAT6—head and neck cancer	8.82e-05	0.00109	CbGpPWpGaD
Modafinil—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—head and neck cancer	8.69e-05	0.00107	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—NAT2—head and neck cancer	8.68e-05	0.00107	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—NAT2—head and neck cancer	8.48e-05	0.00105	CbGpPWpGaD
Modafinil—SLC6A3—Neuronal System—HRAS—head and neck cancer	8.1e-05	0.001	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—YAP1—head and neck cancer	7.8e-05	0.000964	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—DPYD—head and neck cancer	7.61e-05	0.00094	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—DPYD—head and neck cancer	7.44e-05	0.000919	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—YAP1—head and neck cancer	7.22e-05	0.000892	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—YAP1—head and neck cancer	7.06e-05	0.000872	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	6.96e-05	0.000861	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	6.89e-05	0.000852	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—NAT2—head and neck cancer	6.56e-05	0.00081	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	6.35e-05	0.000785	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	6.29e-05	0.000777	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—NAT2—head and neck cancer	5.98e-05	0.000739	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—DPYD—head and neck cancer	5.75e-05	0.000711	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—YAP1—head and neck cancer	5.46e-05	0.000674	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	5.43e-05	0.000671	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	5.37e-05	0.000664	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—DPYD—head and neck cancer	5.24e-05	0.000648	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—NAT2—head and neck cancer	5.11e-05	0.000631	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—YAP1—head and neck cancer	4.97e-05	0.000615	CbGpPWpGaD
Modafinil—ADRA1B—GPCR downstream signaling—IL2—head and neck cancer	4.51e-05	0.000558	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—DPYD—head and neck cancer	4.48e-05	0.000554	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—TYMS—head and neck cancer	4.34e-05	0.000536	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—GSTM1—head and neck cancer	4.29e-05	0.00053	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—YAP1—head and neck cancer	4.25e-05	0.000525	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—TYMS—head and neck cancer	4.24e-05	0.000524	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—GSTM1—head and neck cancer	4.19e-05	0.000518	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—GPX1—head and neck cancer	4.1e-05	0.000507	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	4.1e-05	0.000507	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—IL2—head and neck cancer	4.1e-05	0.000506	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—CYP1A1—head and neck cancer	4.06e-05	0.000502	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—GPX1—head and neck cancer	4.01e-05	0.000496	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—CYP1A1—head and neck cancer	3.97e-05	0.000491	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—NAT2—head and neck cancer	3.94e-05	0.000487	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	3.74e-05	0.000462	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	3.57e-05	0.000442	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—NOTCH1—head and neck cancer	3.52e-05	0.000435	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—DPYD—head and neck cancer	3.46e-05	0.000427	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—MAPK3—head and neck cancer	3.29e-05	0.000407	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—YAP1—head and neck cancer	3.28e-05	0.000405	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—TYMS—head and neck cancer	3.28e-05	0.000405	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	3.26e-05	0.000403	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—GSTM1—head and neck cancer	3.24e-05	0.0004	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	3.19e-05	0.000395	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—MAPK1—head and neck cancer	3.13e-05	0.000387	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—EGFR—head and neck cancer	3.13e-05	0.000387	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—GPX1—head and neck cancer	3.1e-05	0.000383	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—CYP1A1—head and neck cancer	3.07e-05	0.000379	CbGpPWpGaD
Modafinil—ADRA1B—GPCR downstream signaling—PIK3CA—head and neck cancer	2.99e-05	0.00037	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—TYMS—head and neck cancer	2.99e-05	0.000369	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—GSTM1—head and neck cancer	2.95e-05	0.000365	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—GPX1—head and neck cancer	2.83e-05	0.000349	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—CYP1A1—head and neck cancer	2.8e-05	0.000346	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	2.79e-05	0.000344	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—PIK3CA—head and neck cancer	2.72e-05	0.000336	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—TYMS—head and neck cancer	2.55e-05	0.000315	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—GSTM1—head and neck cancer	2.52e-05	0.000312	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	2.52e-05	0.000312	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—HRAS—head and neck cancer	2.52e-05	0.000311	CbGpPWpGaD
Modafinil—ADRA1B—GPCR downstream signaling—AKT1—head and neck cancer	2.45e-05	0.000302	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—IL2—head and neck cancer	2.42e-05	0.000299	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—GPX1—head and neck cancer	2.42e-05	0.000299	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—PTGS2—head and neck cancer	2.42e-05	0.000299	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—CYP1A1—head and neck cancer	2.39e-05	0.000296	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—PTGS2—head and neck cancer	2.36e-05	0.000292	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—CCND1—head and neck cancer	2.36e-05	0.000292	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	2.3e-05	0.000284	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—PTEN—head and neck cancer	2.28e-05	0.000281	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—AKT1—head and neck cancer	2.22e-05	0.000275	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—PTEN—head and neck cancer	2.11e-05	0.00026	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—PTEN—head and neck cancer	2.06e-05	0.000255	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—VEGFA—head and neck cancer	2.06e-05	0.000254	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—STAT3—head and neck cancer	2.04e-05	0.000252	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—TYMS—head and neck cancer	1.97e-05	0.000243	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	1.97e-05	0.000243	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—GSTM1—head and neck cancer	1.95e-05	0.000241	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—MAPK3—head and neck cancer	1.95e-05	0.00024	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—GPX1—head and neck cancer	1.86e-05	0.00023	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—MAPK1—head and neck cancer	1.85e-05	0.000229	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—EGFR—head and neck cancer	1.85e-05	0.000229	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—CYP1A1—head and neck cancer	1.85e-05	0.000228	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—PTGS2—head and neck cancer	1.83e-05	0.000226	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—PTGS2—head and neck cancer	1.66e-05	0.000206	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—PIK3CA—head and neck cancer	1.61e-05	0.000199	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—PTEN—head and neck cancer	1.59e-05	0.000197	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—TP53—head and neck cancer	1.55e-05	0.000192	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—PIK3CA—head and neck cancer	1.49e-05	0.000184	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—HRAS—head and neck cancer	1.49e-05	0.000184	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—PIK3CA—head and neck cancer	1.45e-05	0.00018	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—PTEN—head and neck cancer	1.45e-05	0.000179	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—PTGS2—head and neck cancer	1.42e-05	0.000176	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—AKT1—head and neck cancer	1.31e-05	0.000162	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—PTEN—head and neck cancer	1.24e-05	0.000153	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—AKT1—head and neck cancer	1.21e-05	0.00015	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—AKT1—head and neck cancer	1.19e-05	0.000147	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—PIK3CA—head and neck cancer	1.12e-05	0.000139	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—PTGS2—head and neck cancer	1.1e-05	0.000136	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—PIK3CA—head and neck cancer	1.02e-05	0.000127	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—PTEN—head and neck cancer	9.57e-06	0.000118	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—AKT1—head and neck cancer	9.18e-06	0.000113	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—PIK3CA—head and neck cancer	8.75e-06	0.000108	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—AKT1—head and neck cancer	8.37e-06	0.000103	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—AKT1—head and neck cancer	7.15e-06	8.84e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—PIK3CA—head and neck cancer	6.75e-06	8.35e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—AKT1—head and neck cancer	5.52e-06	6.82e-05	CbGpPWpGaD
